Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Vijaya Diagnostic Centre Ltd Q3FY25; 35% rise in Profits
Categories
Diagnostics
Metropolis Healthcare Ltd Q3FY25; 15% rise in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Metropolis Healthcare Ltd Q2FY25; 31% rise in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Metropolis Healthcare Ltd Q4FY24; 12% rise in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Thyrocare Technologies Ltd Q4FY24; 90% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Vijaya Diagnostic Centre Ltd Q4FY24; 21% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Max Healthcare Institute Ltd Q3FY24; 30% rise in Profits
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and
Dr Lal Pathlabs Ltd Q3FY24; 52% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Metropolis Healthcare Ltd Q3FY24; 25% fall in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Dr Lal PathLabs Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY24 Earnings Concall Financial Performance Revenue for Q2 FY24 was INR601 crores, up
Thyrocare Technologies Ltd Q2FY24; 43% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Vijaya Diagnostic Centre Ltd Q1FY24; 44% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Metropolis Healthcare Ltd Q1FY24; 15% fall in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Thyrocare Technologies Ltd Q1FY24; 5% fall in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Metropolis Healthcare Q4FY23 Earnings Story
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Vijaya Diagnostics Centre Ltd Q4FY23 results out, revenue grows by 4%
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Dr Lal PathLabs Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:17:48] Rahul Agarwal from InCred Capital asked if
Earnings | Dr Lal Path Labs Ltd (NSE:LALPATHLAB): Q3FY23 Results Out; Total Income fell 2% YoY
Dr Lal Path Labs Ltd (NSE:LALPATHLAB) is a leading diagnostic services provider in India. The company was founded in 1949 by Dr.
Vijaya Diagnostic Q3FY23 net profit drops by 35 percent
Vijaya Diagnostic reported total income of INR 116.67 crores during the period ended December 31, 2022 as compared to INR 113.97 crores
Earnings Summary Of Fortis Healthcare Limited For Q3 FY23
Fortis Healthcare Limited (NSE: FORTIS) is one of India's leading healthcare providers, offering a range of medical services across its network of
Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year
Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the previous year.